The presence of INS amyloid in pancreatic islets is a pathological hallmark of T2D, contributing to the gradual loss of β-cell mass and cellular dysfunction (Alrouji et al., 2023; Das et al., 2022; Stanciu et al., 2020). This evidence concerns the gene INS and type 2 diabetes mellitus.